Healthcare business BTG has agreed to acquire EKOS, a US-based maker of ultrasound systems for treating vascular thrombosis backed by US-listed investment bank Morgan Stanley’s growth equity division, for about $180m, plus up to $40m in future milestone payments.
Louise Makin, chief executive of BTG, said: “There is increasing recognition of the benefits of interventional treatment of severe blood clots. EKOS is a fast-growing and profitable business, and the acquisition provides an exciting opportunity to build on our existing interventional medicine business and to enter an area with a significant addressable market opportunity.”
EKOS is a private US corporation owned by its employees and investors including venture capital firms EGS Healthcare Capital Partners, MedVenture Associates and NGN Capital and Morgan Stanley Expansion Capital.